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PRACTICE
Why read this summary?
The prevalence of faecal incontinence in adults living 
in the community is 1-10%, depending on the defini-
tion used.1 2 Faecal incontinence is a neglected problem 
that receives limited medical attention, and despite its 
profound negative impact most patients do not tell their 
doctor about it.3 4 Simple, low cost interventions will 
often improve or even cure symptoms. More sophisti-
cated second line investigations and treatments are avail-
able, but referral for these is not common. This article 
summarises the most recent guidance from the National 
Institute for Health and Clinical Excellence (NICE) on 
managing faecal incontinence in adults.5
Recommendations
NICE recommendations are based on systematic 
reviews of best available evidence. When minimal evi-
dence is available, a range of consensus techniques is 
used to develop recommendations. In this summary, 
recommendations derived primarily from consensus 
techniques are indicated with an asterisk (*).
General approach
All staff working with people with faecal incontinence 
should be aware of the physical and emotional impact 
this condition can have on patients and their carers. 
Consider patients’ needs and preferences when planning 
treatment and ensure they have the opportunity to make 
informed decisions in partnership.
Assessment
Healthcare professionals should actively yet sensitively 
inquire about symptoms of faecal incontinence in high 
risk groups (box).
Faecal incontinence often has several contributory 
factors. Assumptions that it is caused by a single 
primary condition are therefore not appropriate.* 
Before starting treatment, perform a focused baseline 
assessment as follows*:
•  Identify contributory factors from a medical 
history, general and anorectal examination, and, if 
appropriate, cognitive assessment
•  Differentiate between symptoms of urge or passive 
faecal incontinence and the patient’s normal bowel 
habit (note any changes) 
•  Assess diet; medical and obstetric history; lifestyle; 
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mobility; and medications
•  Assess anorectal abnormalities and function or rectal 
loading by visual inspection and digital examination.
Management
Treat the following specific conditions (if identified 
from the assessment), before progressing to more gen-
eral measures*:
•  Faecal loading (treat with rectal or oral medication 
until the rectum is empty)
•  Treatable causes of diarrhoea (for example, 
infective, inflammatory bowel disease, and irritable 
bowel syndrome)
•  Warning signs for colorectal cancer (for example,  
rectal bleeding, unexplained change in bowel 
habit, and anaemia)6
•  Rectal prolapse or third degree haemorrhoids
•  Acute injury to the anal sphincter (will often need 
surgical repair)
•  Cauda equina syndrome or acute disc prolapse.
Once the above conditions have been excluded or 
treated, offer initial conservative measures, tailored to 
the patient’s presenting symptoms, as follows:
•  Try to improve the patient’s bowel habit, aiming for 
an ideal stool consistency and satisfactory bowel 
emptying at a predictable time.* Patient education 
may help to establish a bowel routine (such as going 
to the toilet after a meal to capitalise on the gastrocolic 
response), optimise evacuation (posture and pushing 
without straining), and regulate diet and fluid intake. 
Some patients will benefit from modifying fibre intake 
(an increase or decrease, depending on existing diet 
and stool consistency), reducing caffeine, and ensuring 
easy access to a toilet*
•  Thoroughly review both prescribed and over the 
counter medications.* Side effects of constipation 
or loose stools can underlie faecal incontinence. 
Loperamide hydrochloride is the antidiarrhoeal 
drug of first choice for faecal incontinence associated 
with loose stools when relevant investigation and 
treatment have failed to resolve the loose stools. Start 
at a low dose, and increase until symptom control is 
achieved without troublesome constipation (the syrup 
formulation should be considered for doses under  
2 mg). Loperamide hydrochloride can be used in  
doses up to 16 mg a day on a continuous basis, but 
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many patients need a much lower dose or can use 
only as needed
•  Advise on coping strategies, such as the use of 
continence products (pads or plugs), skin care, and 
access to emotional and psychological support.*
If symptomatic patients do not wish to continue active 
treatment or have intractable symptoms*:
•  Advise on how to preserve dignity and 
independence (such as toilet access and use7)
•  Offer psychological support, with referral to  
counsellors or therapists as appropriate
•  Review symptoms at least every six months
•  Discuss other management options (including  
specialist referral)
•  Provide contact details for relevant support groups
•  Provide information and advice on continence  
products, and provide information on choice of  
products and their availability and use
•  Advise on skin care
•  Discuss how to talk to friends and family
•  Discuss coping strategies, such as planning routes 
around public conveniences when travelling.
Specialist referral
If symptoms continue, consider referral to a specialist 
continence service for options such as a pelvic floor 
re-education programme, bowel retraining, specialist 
dietary assessment and management, biofeedback, 
electrical stimulation, or rectal irrigation.* These 
interventions will usually need to be individually 
tailored and monitored closely (for example, by 
digital reassessment). Some of these treatments 
may not be appropriate for people who cannot 
understand and/or comply with instructions. Pelvic 
floor re-education programmes, for example, 
may not  be  appropr ia te  for  those  wi th 
neurological or spinal disease or injury that 
results in faecal incontinence.*
If specialised investigation is needed, a combination 
of anorectal physiology tests and endoanal 
ultrasonography will assist selection of patients 
for surgery.* Where endoanal ultrasonography 
is not available, magnetic resonance imaging 
or endovaginal ultrasonography and perineal 
ultrasonography may be considered.*
Refer patients considering surgery to a specialist 
surgeon to discuss the potential benefits and limita-
tions of surgical and non-surgical options, particularly 
long term expectations of effectiveness. Most sur-
gery should be conducted in specialist centres. Anal 
sphincter repair has limited long term efficacy and 
should be reserved for patients with major symptoms 
and an external anal sphincter defect of 90 degrees 
or more. Neosphincters, such as an implanted inflat-
able artificial anal sphincter or a transposition of the 
gracilis muscle around the anus, are generally associ-
ated with high complication rates (such as infection, 
erosion, or equipment failure); no long term data are 
available yet for sacral nerve stimulation. Training 
and long term support are needed when implants 
are used.*
Specific groups
Adopt a proactive approach to bowel management for 
the following patient groups, who are prone to faecal 
incontinence or constipation*:
•  People with faecal loading or constipation
•  Acutely unwell and hospitalised patients 
•  Patients  with neurological or spinal conditions 
•  Patients  with limited mobility
•  Severely or terminally ill people
•  Patients with acquired brain injury, learning disabilities, 
or other cognitive or behavioural problems.
Overcoming barriers
The most crucial barriers to implementing this guideline 
may be traditional taboos associated with discussing 
defecation and the stigma of faecal incontinence. 
Many people (including some health professionals) 
do not find it easy to talk about this subject. Local and 
national campaigns may raise awareness and help to 
break down taboos on discussing bowel function.
As a symptom, faecal incontinence does not fall 
under the responsibility of any one professional group. 
A multidisciplinary approach is recommended.* 
Most nurse continence advisers focus on urinary 
incontinence, and many of them may need additional 
training to take a lead on faecal incontinence. 
Specialised investigation and management facilities 
are also lacking.
Although most of this guideline is based on consensus 
methods rather than high quality research evidence, 
the guideline development group believes that the 
commonsense recommendations it contains provide 
a practical approach to managing the common and 
neglected problem of faecal incontinence. We hope 
this guideline will stimulate both clinical and research 
interest in this topic, and that future updates will have 
an expanded evidence base on which to work.
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Groups at high risk of 
faecal incontinence
•	Frail	older	people
•	Patients	with	loose		
stools	or	diarrhoea	from	
any	cause
•	Women	who	have	recently	
given	birth	(especially	
after	third	or	fourth	
degree	obstetric	injury)
•	Patients	with	neurological	
or	spinal	cord	disease	or	
injury
•	Patients	with	severe	
cognitive	impairment	or	
learning	disabilities
•	Patients	with	urinary	
incontinence;	pelvic	
organ	or	rectal	prolapse;	
perianal	soreness,	
itching,	or	pain
•	Patients	who	have	
had	colonic	resection,	
anal	surgery,	or	pelvic	
radiotherapy
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